Published in TB and Outbreaks Week, March 25th, 2003
In a recent study from Brazil, "forty consecutive patients with nosomial infections caused by multidrug-resistant Acinetobacter baumannii were treated with intravenous ampicillin/sulbactam."
Most of the treated patients suffered from "severe infections with underlying conditions (median APACHE II score: 14.5) and 72.5% occurred in the ICU," according to A. S. Levin and colleagues at the University of Sao Paulo.
After treatment, "twenty-seven (67.5%) were improved/cured, seven (17.5%) were failures and six (15%) were...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB and Outbreaks Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.